Download FREE Report Sample
Download Free sampleGlucagon?is a?prescription drug?for injection is a?gastrointestinal?motility inhibitor indicated for use as a diagnostic aid during?radiologic?examinations to temporarily inhibit movement of the gastrointestinal (GI) tract.
Glucagon Drug Market contains market size and forecasts of Glucagon Drug in global, including the following market information:
Global Glucagon Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Glucagon Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Glucagon Drug companies in 2021 (%)
The global Glucagon Drug market was valued at 572.1 million in 2021 and is projected to reach US$ 844.6 million by 2028, at a CAGR of 5.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Inject Glucagon Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glucagon Drug include Novo Nordisk, Eli Lilly, Fresenius Kabi and Torrent Labs, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glucagon Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glucagon Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Glucagon Drug Market Segment Percentages, by Type, 2021 (%)
Inject Glucagon
Nasal Glucagon
Global Glucagon Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Glucagon Drug Market Segment Percentages, by Application, 2021 (%)
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
Global Glucagon Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Glucagon Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glucagon Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Glucagon Drug revenues share in global market, 2021 (%)
Key companies Glucagon Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Glucagon Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy